Lv2
160 积分 2025-04-22 加入
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial
9天前
已完结
Immune archetypes TIME classification system for nasopharyngeal carcinoma: A new direction for precision immunotherapy
2个月前
已关闭
Nasopharyngeal carcinoma
3个月前
已完结
Tumor-Associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers
5个月前
已完结
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
6个月前
已完结
Dysfunctional KLRB1+CD8+ T-cell responses are generated in chronically inflamed systemic sclerosis skin
7个月前
已完结
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
8个月前
已完结
Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
9个月前
已完结
Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding
9个月前
已完结
皖公网安备34019202002308